VYNE Therapeutics (VYNE) Shares Outstanding (Diluted) (2020 - 2026)
VYNE Therapeutics (VYNE) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 680.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | 42.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.77 Mn |
| Dec 31, 2025 | 42.77 Mn |
| Jun 30, 2025 | 42.76 Mn |
| Mar 31, 2025 | 42.67 Mn |
| Dec 31, 2024 | 42.59 Mn |
| Sep 30, 2024 | 42.59 Mn |
| Jun 30, 2024 | 42.59 Mn |
| Mar 31, 2024 | 42.58 Mn |
| Dec 31, 2023 | 10.27 Mn |
| Sep 30, 2023 | 3.28 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.26 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 3.22 Mn |
| Jun 30, 2022 | 3.22 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 2.86 Mn |
| Sep 30, 2021 | 2.89 Mn |
| Jun 30, 2021 | 2.86 Mn |
| Mar 31, 2021 | 2.72 Mn |